Phase 1a/1b study of EP-7041: A novel, potent, selective, small molecule fxia inhibitor

Authors
Category Primary study
JournalCirculation
Year 2017
This article has no abstract
Epistemonikos ID: 0e6ad1c2d1eb58f6e90385144f10c832835369f1
First added on: Feb 08, 2025